Home Cart Sign in  
Chemical Structure| 1415800-43-9 Chemical Structure| 1415800-43-9
Chemical Structure| 1415800-43-9

UNC1215

CAS No.: 1415800-43-9

UNC1215 is a chemical probe for the methyllysine (Kme) reader domain of L3MBTL3 with Kd of 120 nM.

Synonyms: UNC1215

4.5 *For Research Use Only !

Cat. No.: A255611 Purity: 98+%

Change View

Size Price

US Stock

Global Stock

In Stock
1mg łÍǶÊÊ Inquiry Inquiry
5mg łÿǶÊÊ Inquiry Inquiry
10mg łòÿ¶ÊÊ Inquiry Inquiry
25mg łóͶÊÊ Inquiry Inquiry
50mg łÇÊó¶ÊÊ Inquiry Inquiry
100mg łÇó§¶ÊÊ Inquiry Inquiry
250mg ł§Íò¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1mg

    łÍǶÊÊ

  • 5mg

    łÿǶÊÊ

  • 10mg

    łòÿ¶ÊÊ

  • 25mg

    łóͶÊÊ

  • 50mg

    łÇÊó¶ÊÊ

  • 100mg

    łÇó§¶ÊÊ

  • 250mg

    ł§Íò¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of UNC1215

CAS No. :1415800-43-9
Formula : C32H43N5O2
M.W : 529.72
SMILES Code : O=C(C1=CC=C(C(N2CCC(N3CCCC3)CC2)=O)C=C1NC4=CC=CC=C4)N5CCC(N6CCCC6)CC5
Synonyms :
UNC1215
MDL No. :MFCD22683289
InChI Key :PQOOIERVZAXHBP-UHFFFAOYSA-N
Pubchem ID :57339144

Safety of UNC1215

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of UNC1215

epigenetics

Isoform Comparison

Biological Activity

Target
  • bromodomain

    L3MBTL3, IC50:120 nM

    L3MBTL3- D274A, IC50:3.5 μM

In Vitro:

Cell Line
Concentration Treated Time Description Reference
HEK293 cells 50–100 nM To evaluate the effect of UNC1215 on the diffusibility of GFP-3MBT within the nucleus, results showed that UNC1215 promoted the diffusibility of GFP-3MBT within the nucleus. PMC3577944
HEK293 cells 5 μM 3 hours Validate the co-localization of UNC1215 with GFP-L3MBTL3 PMC3846386
G-401 cells 1.75 nmol 1 hour Validate the binding of UNC1215 to endogenous L3MBTL3 PMC3846386
HeLa cells 60 µM 2 days To study the effect of UNC1215 on DNMT1 stability, results showed that UNC1215 treatment led to a decrease in DNMT1 protein levels PMC3961655
HeLa cells 0, 20, 40, 80 µM 2 days To study the effect of different concentrations of UNC1215 on DNMT1 stability, results showed that UNC1215 treatment led to a decrease in DNMT1 protein levels PMC3961655
CNE2-EBV+ 1 μM 12 h To evaluate the effect of JQ1 on c-Myc expression PMC6037792
TWO3-EBV+ 1 μM 12 h To evaluate the effect of JQ1 on c-Myc expression PMC6037792
HT1080 cells 20 μM 12 hours Validate the effect of 1-HE on ferroptosis in HT1080 cells. PMC8329287

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
Mice CNE2-EBV+ tumor model Intraperitoneal injection 20 mg/kg Biweekly for 3 weeks To evaluate the inhibitory effect of JQ1 on CNE2-EBV+ tumor growth PMC6037792
Mice Kidney ischemia/reperfusion model Intraperitoneal injection 50 mg/kg WZ4002, 2.5 mg/kg trametinib WZ4002 daily, trametinib daily for five consecutive days followed by three times weekly, continuous treatment Investigate the role of FAR1 in ferroptosis induced by kidney ischemia/reperfusion. PMC8329287

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.89mL

0.38mL

0.19mL

9.44mL

1.89mL

0.94mL

18.88mL

3.78mL

1.89mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories